Advertisement

Dehydroepiandrosterone markedly inhibits the accumulation of cholesteryl ester in mouse macrophage J774-1 cells

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      To clarify the antiatherogenic mechanism of action of dehydroepiandrosterone (DHEA), we investigated the effects of DHEA on the accumulation of cholesteryl ester (CE) in cultured mouse macrophage J774-1 cells. The accumulation of CE in J774-1 cells in the presence of acetyl low density lipoprotein (AcLDL) and 10−5 mol/1 DHEA was significantly reduced to 30% of the control values for 24 h. The marked effect of DHEA was observed as early as 6 h and continued at least for 48 h. This reduction by DHEA was dose-dependent and occurred starting at a DHEA dose of 5 × 10−7 mol/1 for 24 h. DHEA treatment did not induced any changes in the cell surface binding, cell-association, or degradation of AcLDL. In comparison, the DHEA analogues, 8354 and 8356, which are known to be much stronger inhibitors of glucose 6-phosphate dehydrogenase than DHEA, did not show as marked an effect as DHEA on the accumulation of CE during the first 6 h. However, after 24–48 h of incubation, both 8354 and 8356 caused a marked reduction in the accumulation of CE similar to that observed with DHEA. A quantitative analysis of the cellular cholesterol content revealed that DHEA caused a marked reduction in CE with a concomitant continuous increase in free cholesterol (FC), while the DHEA analogues caused a marked reduction in CE with no change in FC. DHEA demonstrated little inhibitory effect on 25-hydroxycholesterol-driven esterification. Moreover, 10−5 mol/1 DHEA induced a CE reduction in the foam cells induced by AcLDL. The CE-reducing capacity was also observed in the DHEA analogues. This CE-reducing capacity disappeared, however, when acyl CoA:cholesterol acyltransferase inhibitor, 58-035, was also present. Based on these findings, it can be concluded that the inhibitory effect of DHEA on the CE storage in response to AcLDL can be explained, at least in part, by two mechanisms. First, a recently published mechanism, namely, the inhibitory action of DHEA on lysosomal cholesterol transport, correlates well with the inhibition against foam cell transformation by DHEA in the early phase (at 6 h) observed in our study. With regard to the second mechanism, the CE-reducing capacity of DHEA from CE-laden foam cells, which appears to be related to a decreased cholesteryl ester cycle, may contribute to the inhibitory effect on the CE storage in the late phase (at 24 h and 48 h). These phase-specific inhibitory mechanisms of DHEA on the CE-storage may therefore partly explain the antiatherogenic action of DHEA.

      Keywords

      Abbreviations:

      ACAT (acyl-CoA:cholesterol acyltransferase), ACEase (acid cholesterol esterase), AcLDL (acetyl low density lipoprotein), BSA (bovine serum albumin), CE (cholesteryl ester), DHEA (dehydroepiandrosterone), DHEA-S (DHEA-sulfate), db-cAMP (N6,2′-O-dibutyryladenosine 3′,5′-cyclic monophosphate), FC (free cholesterol), G6PDH (glucose 6-phosphate dehydrogenase), LDL (low density lipoprotein), LPDS (lipoprotein-deficient serum), NCEase (neutral cholesterol esterase), PBS (phosphate buffer saline), TC (total cholesterol), TLC (thin-layer chromatography)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ross R
        The pathogenesis of atheroderosis — an update.
        N Engl J Med. 1986; 314: 488
        • Henriksen T
        • Mahoney EM
        • Steinverg D
        Enhanced macrophage degradation of biologically modified low density lipoprotein.
        Arteriosclerosis. 1983; 3: 149
        • Lobo EA
        Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women.
        J Clin Endocrinol Metab. 1991; 73: 925
        • Mazière C
        • Audair M
        • Ronveaux M-F
        • Salmon S
        • Santus R
        • Mazière J-C
        Estrogens inhibit copper and cell-mediated modification of low density lipoprotein.
        Atherosclerosis. 1991; 89: 175
        • Rifici VA
        • Khachadurian AK
        The inhibition of low-density lipoprotein oxidation by 17-β estradiol.
        Metabolism. 1992; 41: 1110
        • Taniguchi S
        • Yanase T
        • Kobayashi K
        • Takayanagi R
        • Haji M
        • Umeda F
        • Nawata H
        Catechol estrogens are more potent antioxidants than estrogens for the Cu2+ -catalyzed oxidation of low or high density lipoprotein: antioxidative effects of steroids on lipoproteins.
        Endocrine J. 1994; 41: 605
        • Orentreich N
        • Brind JL
        • Rizer RL
        • Vogelman JH
        Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood.
        J Clin Endocrinol Metab. 1984; 59: 551
        • Schwartz AG
        Inhibition of spontaneous breast cancer formation in female C3H (Avy/a) mice by long-term treatment with dehydroepiandrosterone.
        Cancer Res. 1979; 39: 1129
        • Yen TY
        • Allan JA
        • Pearson DV
        • Action JM
        Prevention of obesity in Avy/a mice by dehydroepiandrosterone.
        Lipids. 1977; 12: 409
        • Ben-David M
        • Dikstein S
        • Bismuth G
        • Sulman FG
        Antihypercholesterolemic effect of dehydroepiandrosterone in rats.
        in: 7th edn. Proc Soc Exp Biol Med. 125. 1967: 1136
        • Coleman DL
        • Leiter EH
        • Schwier RW
        Therapeutric effect of dehydroepiandrosterone (DHEA) in diabetic mice.
        Diabetes. 1982; 31: 830
        • Nestler JE
        • Barlascini CO
        • Clore JN
        • Blakard WG
        Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men.
        J Clin Endocrinol Metab. 1988; 66: 57
        • Barrett-Connor E
        • Khaw KT
        • Yen SSC
        A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease.
        N Engl J Med. 1986; 315: 1519
        • Gordon GB
        • Bush DE
        • Welsman HF
        Reduction of atherosclerosis by administration of dehydrdepiandrosterone. A study in the hypercholesterolemic New Zealand White Rabbit with aortic intimal injury.
        J Clin Invest. 1988; 82: 712
        • Arad Y
        • Badimon JJ
        • Badimon L
        • Hembree WC
        • Ginsberg HN
        Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit.
        Arteriosclerosis. 1989; 9: 159
        • Eich DM
        • Johnson DE
        • Nestler JE
        • Daijin K
        • Hess ML
        • Wechsler AS
        Inhibition of cardiac allograft atherosclerosis by dehydroepiandrosterone.
        Clin Res. 1990; 38: 2
        • Aikawa K
        • Furuchi T
        • Fujimoto Y
        • Arai H
        • Inoue K
        Structure-specific inhibition of lysosomal cholesterol transport in macrophages by various steroids.
        Biochim Biophys Acta. 1994; 1213: 127
        • Schwartz AG
        • Lewbart ML
        • Pashko LL
        Novel dehydroepiandrosterone analogues with enhanced biological activity and reduced side effects in mice and rats.
        Cancer Res. 1988; 48: 4817
        • Havel RJ
        • Eder HA
        • Bragdon JH
        The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.
        J Clin Invest. 1955; 34: 1345
        • Basu SK
        • Goldstein JL
        • Andersen RGW
        • Brown MS
        Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.
        in: 7th edn. Proc Natl Acad Sci USA. 73. 1976: 3178
        • Bilheimer DW
        • Eisenberg S
        • Levy RI
        The metabolism of very low density lipoproteins. 1. Preliminary in vitro and in vivo observations.
        Biochim Biophys Acta. 1972; 260: 212
        • Brown MS
        • Ho YK
        • Goldstein JL
        The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cyto-plasmic cholesteryl esters.
        J Biol Chem. 1980; 255: 9344
        • Goldstein JL
        • Brown MS
        Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hyper cholesterolemia.
        J Biol Chem. 1974; 249: 5153
        • Bierman EL
        • Stein O
        • Stein Y
        Lipoprotein uptake and metabolism by rat aortic smooth musde cells in tissue culture.
        Circ Res. 1974; 35: 136
        • van Hinsberg VMW
        • Havekes L
        • Emeis JJ
        • van Corven E
        • Scheffer M
        Low density lipoprotein metabolism by endothelial cells from human umbilical cord arteries and veins.
        Arteriosclerosis. 1983; 3: 547
        • Bernard DW
        • Rodriguez A
        • Rothblat GH
        • Glick JM
        Influence of high-density lipoprotein on esterified cholesterol stores in macrophages and hepatoma cells.
        Arteriosclerosis. 1990; 10: 135
        • Bernard DW
        • Rodriguez A
        • Rothblat GH
        • Glick JM
        cAMP stimulates cholesteryl ester dearance to high density lipoprotein in J774 macrophages.
        J Biol Chem. 1991; 266: 710
        • Ho YK
        • Brown SM
        • Goldstein JL
        Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density iipoprotein and other agents.
        J Lipid Res. 1980; 21: 391
        • Small DM
        Cellular mechanisms for lipid deposition in atherosderosis (first of two parts).
        N Engl J Med. 1977; 297: 873
        • Small DM
        Cellular mechanisms for lipid deposition in atherosderosis (second of two parts).
        N Engl J Med. 1977; 297: 924
        • Hajjar DP
        • Minick CR
        • Fowler S
        Arterial neutral cholesteryl esterase. A hormone sensitive enzyme distinct from lysosomal cholesteryl esterase.
        J Biol Chem. 1982; 258: 192
        • Shantz LM
        • Talalay P
        • Gordon GB
        Mechanism of inhibition of growth of 3T3-L1 fibroblasts and their differentiation to adipocytes by dehydroepiandrosterone and related steroids: role of glucose-6-phosphate dehydrogenase.
        in: 7th edn. Proc Natl Acad Sci USA. 86. 1989: 3852
        • Yamada J
        • Sakura M
        • Suga T
        Induction of peroxisomal β-oxidation enzymes by dehydroepiandrosterone and its sulfate in primary cultures of rat hepatocytes.
        Biochim Biophys Acta. 1992; 1160: 231
        • Butler JD
        • Blanchette-Mackie J
        • Goldin E
        • O'Neill RR
        • Carstea G
        • Roff CF
        • Patterson MC
        • Patel S
        • Cimly ME
        • Cooney A
        • Vanier MT
        • Brdy RO
        • Pentchev PG
        Progesterone blocks cholesterol translocation from lysosomes.
        J Bio Chem. 1992; 267: 23797
        • Mazzone T
        • Krishna M
        • Lange Y
        Progesterone blocks intracellular translocation of free cholesterol derived from cholesteryl ester in macrophages.
        J Lipid Res. 1995; 36: 544
        • Schwartz AG
        • Whitconb JM
        • Nyce JW
        • Lewbart ML
        • Pashko LL
        Dehydroepiandrosterone and structural analogues: a new dass of cancer chemopreventive agents.
        Adv Cancer Res. 1988; 51: 391
        • Schwartz AG
        • Fairman DK
        • Ploansky M
        • Lewbart ML
        • Pashko LL
        Inhibition of 7,12-dimethylbenz[a]anthracene-initiated and 12-O-tetradecanoylphorbol-13-acetate-promoted skin papillom a formation in mice by dehydroepiandrosterone and two synthetic analogues.
        Carcinogenesis. 1989; 10: 1809
        • Daynes RA
        • Araneo BO
        • Dowell TD
        • Huang K
        • Dudley D
        Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenviroment exerts regulatory influences over T helper cell function.
        J Exp Med. 1990; 171: 979